Rasph

Strolll and the EIC Accelerator: AR Glasses to Help People Walk

September 30, 2026871 words5 min

Strolll, founded by Tom Finn and based in Stafford, England, uses augmented reality glasses to show visual cues, such as lines on the floor, that help people with Parkinson's disease and other neurological conditions start walking when their gait freezes. The idea came in 2018, when Finn saw his father walk again after a physiotherapist laid coloured strips across the kitchen floor, according to Strolll. In the EIC Accelerator's June 2023 cut-off it was selected, with a grant-only award, for NavigAIt, "an artificial intelligence application for augmented reality glasses to provide intelligent on-demand cueing to assist everyday walking for people with Parkinson's disease anywhere, anytime". Strolll does not appear in CORDIS, the EU's project database, so the project's budget, dates and reports are not public.

In March 2025 Strolll raised a €12.2 million Series A led by IW Capital, according to EU-Startups. Its website now describes a product that helps "clinicians deliver more engaging and effective neuro rehabilitation" in therapy sessions, according to Strolll. Studies of its home-based augmented reality gait and balance therapy for Parkinson's have been published in Physical Therapy, according to Oxford Academic. An everyday, on-demand walking aid, the product named in the EIC award, is not listed.

€12.2MSeries A, March 2025
29Average employees, 2025
£3.65MCash, end of 2025
Not in CORDISEIC project record

Company file

Legal entity
Strolll Limited, company 11832565
Founder
Tom Finn
Chief executive, 2025
Jorgen Ellis, co-founder
Product
Augmented reality neurorehabilitation
Lead investor
IW Capital
Conditions
Parkinson's, stroke, multiple sclerosis
EIC funding
Grant only

Where Strolll Stands Now

Strolll's accounts for 2025 show average staff of 29, up from 12 in 2023, cash of £3.65 million and net assets of £7.38 million, according to filings at Companies House. The filings also show the lead investor's nominee becoming a person with significant control in February 2026, co-founder Jorgen Ellis ceasing to be one, a charge registered in June 2026 and further share allotments in August and September 2026. The company's revenue is not shown in its abbreviated accounts.

"Today, Strolll brings visual cueing, movement, and progression into the real environment through augmented reality, helping clinicians deliver more engaging and effective neuro rehabilitation."

Strolll, website

The Technology: Cues Only the Patient Can See

Freezing of gait is a sudden inability to take the next step. Strolll's founder saw visual cues on the floor release his father from it, but such cues have to be set up in advance. Strolll's glasses project cues and gamified exercises into the patient's field of view. The EIC project aimed to add artificial intelligence so that cues appear on demand, wherever and whenever the wearer freezes.

What the EIC Award Promised, and What the Record Shows

The award described an AI application for everyday walking, anywhere, at any time. What the record shows is a company that has grown quickly and raised significant private capital around clinical and home rehabilitation. Whether the on-demand AI cueing was built, and how the EIC money was spent, cannot be checked because no project record is public.

  1. AR rehabilitation productDeliveredOn the market.
  2. On-demand everyday cueingUnverifiedNot listed.
  3. Clinical evidenceGrowingPublished studies.
  4. EIC project reportingUnverifiedNot in CORDIS.

The Money

The €12.2 million Series A in 2025 transformed Strolll's balance sheet, which had shrunk in 2024. The size of the EIC grant has not been published by the company, and whether it was paid by the EU or by Innovate UK under the UK's Horizon Europe arrangements is not public.

What Cannot Be Checked

Questions for the EIC

How much Strolll received, what NavigAIt delivered, whether the AI cueing reached users outside clinics, and what Strolll's revenue is are not public.

Why Europe Should Care

A wearable aid that works at home and outdoors, not only in therapy sessions, would matter to people whose walking freezes without warning. Strolll has built a business in rehabilitation; the everyday aid the EIC backed is still to be seen.

What the award promised

AI on augmented reality glasses to help people with Parkinson's walk anywhere, anytime.

What the record shows

A growing clinic-focused rehab company with €12.2M raised and no public EIC project record.

The Verdict

Thriving, off the brief

Strolll is growing and well funded. What the EIC's money produced for everyday walking is not documented.

Strolll and the EIC have not been asked for comment for this article. It is based entirely on public records and published statements, linked throughout.

Start with the EIC Accelerator

Professional proposal writing and expert review for Step 1 and Step 2.

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges is a new pilot program offering €300,000 (Stage 1) and up to €2.5 million (Stage 2) for breakthrough deep-tech solutions through ARPA-style staged funding with demand-side integration. The program targets single entities or small consortia (2-3 partners) including SMEs, start-ups, and research organizations. Focus areas include Physical AI for autonomous robotics and New Approach Methodologies (NAMs) for animal-free biomedical testing, requiring TRL 4 entry with end-user commitment.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
EIC AcceleratorBeneficiary Deep Dive#Strolll#Parkinson's disease#augmented reality#rehabilitation#digital health#United Kingdom
Loading